Dow Down 0.22% Nasdaq Up 0.14%

Ligand Pharmaceuticals Incorporated (LGND)

-NasdaqGM
51.24 Down 0.51(0.99%) 4:00PM EDT
|After Hours : 51.24 0.00 (0.00%) 4:27PM EDT
Prev Close:51.75
Open:51.75
Bid:49.51 x 100
Ask:54.50 x 100
1y Target Est:84.80
Beta:0.95
Earnings Date:Oct 28 - Nov 3 (Est.)
Day's Range:50.85 - 52.22
52wk Range:39.75 - 80.42
Volume:365,471
Avg Vol (3m):381,741
Market Cap:1.06B
P/E (ttm):87.89
EPS (ttm):0.58
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for LGND

Comparison

Symbol% ChgMkt Cap
LGNDDown 0.99%1.06B
LLYUp 0.47%66.79B
MRKUp 0.54%170.68B
RHHBYDown 0.33%246.79B

Key Statistics

Forward P/E (1 yr):21.09
P/S (ttm):19.80
Ex-Dividend Date:02-Jul-10

Analysts

Annual EPS Est (Dec-14) :1.55
Quarterly EPS Est (Sep-14) :0.32
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.11

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Ligand Pharmaceuticals Incorporated, a biotechnology company, acquires and develops royalty revenue generating assets in the United States. Its late-stage development programs include Promacta, an oral thrombopoietin receptor agonist therapy for t... View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback